North America Healthcare Biometrics Market: By Mode (Physical Access Control, Logical Access Control, Transaction Authentication), By Technology (Iris Recognition, Signature Recognition, Face Recognition, Hand Recognition, Fingerprint Recognition, Voice Recognition, Vein Recognition) By End-user (Clinics, Healthcare Institutions, Clinical Laboratories, Hospital laboratories, Research lab) and By Country (U.S. and Canada)

 

North America Healthcare Biometrics Market is expected to grow at a CAGR of 15% during the forecast period 2022 to 2028. Biometrics is a vital tool in data threats and cyber threats. Biometric system is used across various industries like banking, defense, healthcare, mobile and technology, government, security etc. Biometric system plays an essential role in the healthcare industry which enables the proper security of IT processes related to healthcare data by preventing free access to data by identifying individual features like palm prints, fingerprints, voice, DNA, face etc.  As per to the 2014 report of Identity Theft Resource Centre, about 45% of all data violations of identity thefts are from the healthcare industry. As per to the Coalition Against Insurance Fraud- an anti-fraud watchdog group reported that about USD 80Bn is annually lost in the US in Medicare fraud. Moreover, growing adaptability of the biometrics system in healthcare sectors such as research labs, clinical laboratories, and hospitals etc., increase in technological advancements are the few other factors which are propelling the growth of the North America Healthcare Biometrics Market. Government of U.S. provides various regulations for the biometric security systems such as Health Insurance Portability and accountability act (HIPAA) which is enforced by the Medicare and Medicaid Services (CMS) and Electronic Protected Health Information etc. On the other side, security and convenience trade-off and biometric template storage are the factors that are hampering the growth of the North America Healthcare Biometrics Market.